Thus, the aim of the present study was to carry out an audit to assess and compare the maternal characteristics and perinatal outcomes of women with GDM treated with metformin (with or without supplemental insulin), in comparison to those treated solely with insulin or diet and lifestyle modification alone at our large tertiary referral hospital obstetric clinic in Sydney, Australia. This evidence concerns the gene INS and gestational diabetes.